Health
Antidepressant drug fluvoxamine may prevent some serious complications of COVID-19 – News-Medical.Net
In a preliminary study of COVID-19 patients with mild-to-moderate disease who were attempting to recover in their homes, researchers at Washington University School…
Reviewed by Emily Henderson, B.Sc.Nov 12 2020
In a preliminary study of COVID-19 patients with mild-to-moderate disease who were attempting to recover in their homes, researchers at Washington University School of Medicine in St. Louis have found that the drug fluvoxamine seems to prevent some of the most serious complications of the illness and make hospitalization and the need for supplemental oxygen less likely.
The study, a collaboration between the university’s Department of Psychiatry and…
-
Noosa News21 hours agoQueensland’s bid for net zero by 2050 unlikely under new energy plan: expert
-
General22 hours agoMaría Corina Machado awarded Nobel Peace Prize
-
General20 hours agoWestern Bulldogs extend Essendon’s losing streak with 57 point thrashing
-
Business10 hours agoThese 4 ASX mining stocks are rocketing as the rare earths boom intensifies